New Guidelines from CDC and AAP Highlight Differences in Childhood Vaccination Recommendations
The U.S. Centers for Disease Control and Prevention (CDC) has recently released updated guidelines that differ from those of the American Academy of Pediatrics (AAP) for the first time in over 30 years. These changes reflect evolving medical insights and the need to ensure that families receive accurate, research-based information about childhood vaccinations.
The new guidelines from both organizations still emphasize the importance of getting vaccinated against COVID-19 for children six months and older who are immunocompromised. However, there is a notable shift in how they approach vaccination recommendations for children without underlying health conditions. Despite these differences, the AAP continues to advocate for the importance of vaccines for all children, regardless of their immune status.
Ashleigh Burt, a pediatrician in central Iowa and a member of the Executive Board for the Iowa chapter of the AAP, explains that while the CDC and AAP have historically aligned on many vaccination policies, recent changes in the CDC’s advisory panel have prompted the AAP to issue its own set of guidelines. “My goal when I go to work every day is to provide the best care possible,” Burt said. “That isn’t a one-sided situation.”
Burt notes that the AAP wants to ensure that families receive recommendations based on the latest research and data. She explained that the CDC’s updated approach to vaccine recommendations has created a gap in clear guidance for providers and families. “The CDC now suggests that for children who are not immunocompromised, the decision to vaccinate should be made through shared clinical decision-making between the provider and the family,” she said.
This approach differs from other types of immunizations, such as routine or catch-up vaccinations, where the default recommendation is typically to proceed with the vaccine. Shared clinical decision-making involves considering factors like the individual’s health, values, and preferences, as well as the provider’s clinical judgment. However, Burt points out that this lack of a standardized protocol can lead to confusion.
“What makes that hard is that it’s not a standard of care,” Burt said. “Every clinician approaches the recommendation differently, which doesn’t provide clear guidance for families or providers.”
This ambiguity can be particularly challenging in rural areas, where there may be fewer pediatricians and more family medicine providers. Burt highlighted that in such settings, the lack of clear guidelines can make it difficult for providers to know what to recommend and for families to understand what is best for their children.
“There’s a lot of opinions and misinformation that can make these discussions really hard to navigate for both the provider and the family,” Burt said. “It can be hard for them sometimes and even for us as pediatricians to know what’s really true and what’s not.”
Despite these challenges, the AAP continues to recommend that all infants between the ages of six to 23 months receive the COVID vaccine. This aligns with similar guidance from the American College of Obstetricians and Gynecologists, which advises pregnant or nursing individuals to get vaccinated, even though the CDC no longer recommends these shots.
These updates highlight the ongoing evolution of public health policy and the importance of clear, consistent communication between healthcare providers and families. As new data emerges, it will be essential for organizations like the CDC and AAP to work together to ensure that all children receive the best possible care.
